<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Fierstra J</dc:creator>
  <dc:creator>van Niftrik C</dc:creator>
  <dc:creator>Piccirelli M</dc:creator>
  <dc:creator>Bozinov O</dc:creator>
  <dc:creator>Pangalu A</dc:creator>
  <dc:creator>Krayenbühl N</dc:creator>
  <dc:creator>Valavanis A</dc:creator>
  <dc:creator>Weller M</dc:creator>
  <dc:creator>Regli L</dc:creator>
  <dc:date>2018</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">PURPOSE
Cerebral diffuse gliomas exhibit perilesional impaired cerebrovascular reactivity (CVR), yet the degree of impairment as well as its full spatial extent in the brain remains unknown. With quantitative fMRI, we studied twelve subjects with untreated brain diffuse glioma and twelve healthy controls to assess CVR impairment and determine its distribution throughout the brain.


METHODS
In a prospective case-control study, quantitative CVR measurements were derived from BOLD fMRI volumes during standardized iso-oxic changes in carbon dioxide. Whole brain CVR was assessed with additional detailed analyses using specific tumor and tissue masks and compared to datasets of healthy controls.


RESULTS
Whole brain CVR was significantly impaired compared to healthy controls (0.11±0.10 versus 0.28±0.8, p&lt;0.01). All diffuse glioma patients exhibited even more severely impaired intralesional CVR (mean 0.01±0.06). Increasing tumor volume significantly correlated with severity of intralesional CVR impairment (p&lt;0.05, R2=0.38), and whole brain CVR impairment (p&lt;0.05, R2=0.55).


CONCLUSION
Patients with brain diffuse glioma exhibit intralesional and whole brain impaired CVR with severity correlating to tumor volume. Quantitative fMRI may be entertained to study antitumor therapy efficacy by tracking CVR changes and may have a complementary role to better interpret BOLD associated neurovascular uncoupling.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/47364</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/j.mri.2017.09.017</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/28986176</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>Magnetic resonance imaging. - 2018</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">BOLD</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Carbon dioxide</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Cerebrovascular reactivity</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Diffuse glioma</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">fMRI</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Adult</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Aged</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Aged, 80 and over</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Brain</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Brain Mapping</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Brain Neoplasms</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Case-Control Studies</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Cerebrovascular Circulation</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Glioma</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">Magnetic Resonance Imaging</dc:subject>
  <dc:subject xmlns:ns18="xml" ns18:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns19="xml" ns19:lang="en">Middle Aged</dc:subject>
  <dc:subject xmlns:ns20="xml" ns20:lang="en">Prospective Studies</dc:subject>
  <dc:title xmlns:ns21="xml" ns21:lang="en">Diffuse gliomas exhibit whole brain impaired cerebrovascular reactivity.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
